Presented by Equitas Health, the Dr. Robert J. Fass Memorial AIDS Walk Ohio has raised more than $2 million for HIV/AIDS ...
UNAIDS commends the Global Fund to Fight AIDS, TB and Malaria and the United States for their commitment to further increase access to long-acting HIV prevention medication. In a recent statement they ...
AUSTIN (KXAN) — Advocates for HIV prevention are calling a newly approved injectable medication a major step in eliminating the spread of the virus. This summer, the FDA approved Gilead’s lenacapavir, ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. State Department, the United States President’s Emergency ...
U.S. work combatting HIV/AIDS has saved millions of lives globally. Under the Trump administration, funding has been slow in ...
Lenacapavir represents a paradigm shift in HIV prevention, offering a long-acting injectable option administered once every ...
Len is a gamechanging drug to prevent HIV infections, priced by Gilead at $28,200. Limited drug is available at cost to ...
As part of its effort to prevent and treat HIV, Philadelphia has launched a new online tool to connect people with a range of sexual health and community resources. "When we were doing a survey of the ...
Spotlight, the Midwest's largest HIV arts fundraiser, is scheduled for April 20, 2026, at Clowes Memorial Hall at Butler University to benefit the Indiana AIDS Fund, which has provided more than $50 ...
Uganda is taking a giant leap towards an HIV-free generation. This Friday, the country will launch Lenacapavir, a long-acting ...
The number of Latinos with HIV or AIDS in Chicago grew nearly 17% between 2020 to 2024 while other racial groups saw a drop, according to city data. This comes as public health faces a funding crunch.
India, April 16 -- India must digitize procurement and build healthcare reserves to secure HIV prevention against global and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results